Get Ahead with IPO Insights, IPO Prophet

IPO Prophet

At IPO Prophet®, our team leverages over three decades of expertise to deliver actionable quantitative analytics for the IPO market in real-time. This platform synthesizes our extensive experience investing in IPOs, providing investors with revolutionary tools to navigate the complexities of issuance day. Our mission is to empower investors with data-driven insights to make more informed decisions.

Get Ahead with IPO Insights

Equity Capital Markets

<ul><li>December 17, 2025 — Medline Industries, Inc. (NASDAQ: MDLN) began trading today on the Nasdaq Global Select Market following the pricing of its initial public offering at $29.00 per share.</li><li>Shares opened at $35.00 in their first public trade, representing an immediate gain of approximately 21 percent, and continued to build momentum throughout the session.</li><li>By the close, the stock finished near $41.00, delivering a first-day increase of roughly forty percent and marking one of the most consequential IPO debuts of 2025.</li></ul>

December 17, 2025 — Medline Industries, Inc. (NASDAQ: MDLN) began trading today on the Nasdaq Global Select Market following the pricing of its initial public offering at $29.00 per share.Shares opened at $35.00 in their first public trade, representing an immediate gain of approximately 21 percent, and continued to build momentum throughout the session.By the close, the stock finished near $41.00, delivering a first-day increase of roughly forty percent and marking one of the most consequential IPO debuts of 2025.

Medline Returns to Public Markets in Landmark IPO Debut